v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues
Costs and expenses:    
Research and development costs 91,457 119,064
General and administrative costs 615,483 847,815
Total costs and expenses 706,940 966,879
Loss from operations (706,940) (966,879)
Interest income 441 2,859
Interest expense (3,135) (7,186)
Foreign currency gain (loss) 79 (116)
Net loss $ (709,555) $ (971,322)
Net loss per common share basic $ (0.29) $ (0.43)
Net loss per common share diluted $ (0.29) $ (0.43)
Weighted average common shares outstanding basic 2,471,513 2,249,290
Weighted average common shares outstanding diluted 2,471,513 2,249,290

Source